RXT vs. SYRE

Last updated Jun 4, 2026

RXT (Rackspace Technology, Inc.) and SYRE (Spyre Therapeutics Inc.) are both stocks. RXT operates in Software - Infrastructure (Technology), while SYRE operates in Biotechnology (Healthcare). Over the past 5 years, RXT returned -24.22%/yr vs -14.85%/yr for SYRE. At a 0.17 correlation, their price movements are largely independent.

Performance

RXT vs. SYRE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rackspace Technology, Inc. (RXT) and Spyre Therapeutics Inc. (SYRE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RXT achieves a 436.62% return, which is significantly higher than SYRE's 124.42% return.

RXT

• 1D: -4.40%
• 1M: 159.20%
• YTD: 436.62%
• 6M: 405.83%
• 1Y: 405.83%
• 3Y*: 43.58%
• 5Y*: -24.22%
• 10Y*: —

SYRE

• 1D: 6.30%
• 1M: 6.35%
• YTD: 124.42%
• 6M: 128.32%
• 1Y: 343.69%
• 3Y*: 184.28%
• 5Y*: -14.85%
• 10Y*: -9.06%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RXT vs. SYRE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
RXT Rackspace Technology, Inc.	436.62%	-56.07%	10.50%	-32.20%	-78.10%	-29.33%	16.29%
SYRE Spyre Therapeutics Inc.	124.42%	40.72%	8.18%	91.33%	-90.53%	-39.64%	13.40%

Correlation

The correlation between RXT and SYRE is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.16
Correlation (3Y) Calculated over the trailing 3-year period	0.15
Correlation (5Y) Calculated over the trailing 5-year period	0.18
Correlation (All Time) Calculated using the full available price history since Aug 6, 2020	0.17

Fundamentals

Market Cap RXT : $1.30B SYRE : $25.44B
EPS RXT : -$0.60 SYRE : -$0.88
PS Ratio RXT : 0.47 SYRE : 165.17
Total Revenue (TTM) RXT : $2.70B SYRE : $90.49M
Gross Profit (TTM) RXT : $498.60M SYRE : $0.00
EBITDA (TTM) RXT : $149.50M SYRE : -$171.29M

Return for Risk

RXT vs. SYRE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RXT

RXT Risk / Return Rank: 91
RXT Sharpe Ratio Rank: 81
RXT Sortino Ratio Rank: 98
RXT Omega Ratio Rank: 95
RXT Calmar Ratio Rank: 92
RXT Martin Ratio Rank: 89

SYRE

SYRE Risk / Return Rank: 98
SYRE Sharpe Ratio Rank: 99
SYRE Sortino Ratio Rank: 97
SYRE Omega Ratio Rank: 95
SYRE Calmar Ratio Rank: 99
SYRE Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RXT vs. SYRE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Rackspace Technology, Inc. (RXT) and Spyre Therapeutics Inc. (SYRE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RXT	SYRE	Difference
Sharpe ratio Return per unit of total volatility	1.46	5.11	-3.64
Sortino ratio Return per unit of downside risk	5.34	4.84	+0.51
Omega ratio Gain probability vs. loss probability	1.57	1.58	-0.01
Calmar ratio Return relative to maximum drawdown	5.27	16.57	-11.30
Martin ratio Return relative to average drawdown	11.92	40.31	-28.39
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RXT vs. SYRE - Sharpe Ratio Comparison

The current RXT Sharpe Ratio is 1.46, which is lower than the SYRE Sharpe Ratio of 5.11. The chart below compares the historical Sharpe Ratios of RXT and SYRE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	RXT	SYRE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.46	5.11	-3.64
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.17	-0.08	-0.08
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.07	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.13	-0.08	-0.05

Drawdowns

RXT vs. SYRE - Drawdown Comparison

The maximum RXT drawdown since its inception was -98.43%, roughly equal to the maximum SYRE drawdown of -99.11%. Use the drawdown chart below to compare losses from any high point for RXT and SYRE.

Drawdown Indicators

	RXT	SYRE	Difference
Max Drawdown Largest peak-to-trough decline	-98.43%	-99.11%	+0.68%
Max Drawdown (1Y) Largest decline over 1 year	-77.65%	-20.91%	-56.74%
Max Drawdown (3Y) Largest decline over 3 years	-86.50%	-73.99%	-12.51%
Max Drawdown (5Y) Largest decline over 5 years	-98.08%	-98.74%	+0.66%
Max Drawdown (10Y) Largest decline over 10 years	—	-99.04%	—
Current Drawdown Current decline from peak	-80.02%	-75.47%	-4.55%
Average Drawdown Average peak-to-trough decline	-71.95%	-62.67%	-9.28%
Ulcer Index Depth and duration of drawdowns from previous peaks	34.25%	8.58%	+25.67%

Volatility

RXT vs. SYRE - Volatility Comparison

Rackspace Technology, Inc. (RXT) has a higher volatility of 89.50% compared to Spyre Therapeutics Inc. (SYRE) at 15.73%. This indicates that RXT's price experiences larger fluctuations and is considered to be riskier than SYRE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RXT	SYRE	Difference
Volatility (1M) Calculated over the trailing 1-month period	89.50%	15.73%	+73.77%
Volatility (6M) Calculated over the trailing 6-month period	178.10%	45.84%	+132.26%
Volatility (1Y) Calculated over the trailing 1-year period	279.73%	68.18%	+211.55%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	146.72%	179.00%	-32.28%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	137.57%	136.29%	+1.28%

Dividends

RXT vs. SYRE - Dividend Comparison

Neither RXT nor SYRE has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both RXT and SYRE in my portfolio?

RXT and SYRE have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RXT or SYRE?

RXT has higher volatility (89.50%) compared to SYRE (15.73%). In terms of maximum drawdown, RXT dropped -98.43% vs SYRE's -99.11%.

Which has better risk-adjusted returns?

SYRE currently has the higher Sharpe Ratio (5.11 vs 1.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.